AI for Neurology Market worth USD 6,694.1 million by 2035
Market Overview
According to Dimension Market Research, the Global AI for Neurology Market size is estimated at USD 927.5 million in 2026 and is expected to reach USD 6,694.1 million by 2035, expanding at a CAGR of 24.6%, driven by advancements in AI-enabled neuroimaging analysis, real-time neurological data processing from wearables and EEG, integration of evidence-based clinical decision support for brain disorders, and the development of interoperable neurotechnology ecosystems.
AI technologies are becoming vital tools for neurologists, radiologists, and neuroscientists aiming to enhance diagnosis accuracy, forecast disease progression, and customize treatment plans for patients with brain disorders. These systems utilize deep learning algorithms, computer vision, and natural language processing to analyze medical images, interpret EEG signals, and extract insights from electronic health records.
Regional Analysis
North America is projected to take the lead in the global AI for neurology market (by value), covering a market share of about 50.2% in the year 2026. The region's dominance is driven by strong neurology R&D workload cadence (US-based NIH BRAIN Initiative and NINDS programs), high AI software prices relative to other regions, a mature health IT supply chain for advanced interoperability and high-speed medical image exchange, and the presence of key AI vendors and computational neuroscience labs. The widespread adoption of advanced machine learning and computer vision-based AI neurology for stroke, Alzheimer's, and brain tumors further strengthens North America's leading position in the market. Additionally, continuous investments in AI-enabled diagnostic logic monitoring and interoperability capabilities are further reinforcing regional technological leadership.
Europe holds a substantial share of the AI for neurology market due to strong public healthcare systems, collaborative research networks, and growing adoption of AI in radiology and neurology departments across Germany, France, the United Kingdom, Switzerland, and the Netherlands.
Asia Pacific is emerging as a fast-growing region in the AI for neurology market. Rapidly aging populations, increasing prevalence of neurological disorders, government AI initiatives, and expanding healthcare infrastructure in countries such as China, Japan, South Korea, India, and Australia are driving regional demand.
Latin America is experiencing steady growth in AI neurology adoption as healthcare systems modernize and awareness of advanced diagnostic tools increases in Brazil, Mexico, Argentina, and Chile.
Middle East & Africa is gradually adopting AI for neurology technologies as regional governments invest in smart healthcare initiatives and specialty care development, particularly in the United Arab Emirates, Saudi Arabia, Israel, and South Africa.
Request a Complimentary PDF Sample
https://dimensionmarketresearc....h.com/request-sample
FAQs
What is the expected size of the AI for Neurology Market in 2026?
The market is expected to reach USD 927.5 million in 2026.
What is the projected market value by 2035?
The market is forecast to reach USD 6,694.1 million by 2035.
What is the CAGR of the AI for Neurology Market?
The market is expected to grow at a CAGR of 24.6% during 2026–2035.
Summary of Key Insights
The global AI for Neurology Market is expected to grow from USD 927.5 million in 2026 to USD 6,694.1 million by 2035, recording a CAGR of 24.6% during the forecast period. Neuroimaging analysis leads the application segment with 45.0% share, while hospitals and diagnostic imaging centers represent 60.0% of end-user share. Machine learning and deep learning lead technology with 70.0% share. North America holds the largest regional share with approximately 50.2% of global revenue in 2026.
Purchase the Full Report
https://dimensionmarketresearc....h.com/checkout/ai-fo
